Stocks and Investing
Stocks and Investing
Mon, November 13, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tim Lugo Downgraded (ACRS) to Hold on, Nov 13th, 2023
Tim Lugo of William Blair, Downgraded "Aclaris Therapeutics, Inc." (ACRS) to Hold on, Nov 13th, 2023.
Tim has made no other calls on ACRS in the last 4 months.
There are 3 other peers that have a rating on ACRS. Out of the 3 peers that are also analyzing ACRS, 0 agree with Tim's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tim
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $38 on, Monday, October 9th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Wednesday, October 4th, 2023
- Gavin Clark-Gartner of "Evercore ISI Group" Initiated at Buy and Held Target at $22 on, Tuesday, October 3rd, 2023
Contributing Sources